Rapping Our Strength Around Type 1 Diabetes
The 29th annual Juvenile Diabetes Research Fund (JDRF) Real Estate Games were nothing short of fun. Team Rappaport took a break from the office, along with 130 other area real estate companies, and gathered at American University for a day of games and giving back. This year’s games exceed expectations yet again, raising $528,000 to fund research for Type 1 Diabetes (T1D). With over 2,500 participants ready to compete and cheer, the games were exciting for everyone in attendance.
The Rappaport team took part in a variety of traditional and some very unique events throughout the day. Team Rappaport showed out in our vibrant blue “RAPPing our strength around T1D” t-shirts, designed by Senior Graphic Designer, Trevor Ferkler, with lots of enthusiasm and spirit. Team Rappaport rallied around our colleagues as they gave their all in each event we participated in. Scott Price, Vice President of Property Management, laced up his running shoes again on the outside track for the 100M dash. With coworkers cheering and the crowd encouraging, he impressively finished in 2nd place, another top 3 finish for him in the past 3 years.
For Melin Ross, Executive Assistant Investor Relations, this year’s JDRF Games really left an impression. “I participated in my first JDRF Real Estate Games this year and it was truly an amazing experience! I was overjoyed seeing all the awareness being brought to Type 1 Diabetes. As someone that lives with this disease every day, it gave me so much hope to see such a large and well-attended event aimed at raising funds for a cure, education and awareness,” said Ross.
JDRF and the Washington, D.C., real estate community continue to support and raise awareness for T1D. JDRF Real Estate Games founder, Adam Singer, has expanded these games to 2 other cities, with New York City competing in their 3rd annual games this year and Chicago their first.
As a company, Rappaport looks forward to this day and event every year. We are already excited for next year’s games and a future without the impacts of Type 1 Diabetes.